Methylprednisolone and Reflux oesophagitis - a phase IV clinical study of FDA data

Summary:

Reflux oesophagitis is reported as a side effect among people who take Methylprednisolone (methylprednisolone), especially for people who are female, 30-39 old, also take Neupogen, and have Sleep apnea syndrome.

The phase IV clinical study analyzes which people have Reflux oesophagitis when taking Methylprednisolone. It is created by eHealthMe based on reports of 58,374 people who have side effects when taking Methylprednisolone from the FDA, and is updated regularly.

What is Methylprednisolone?

Methylprednisolone has active ingredients of methylprednisolone. It is often used in inflammation. eHealthMe is studying from 59,645 Methylprednisolone users. Check the latest studies of Methylprednisolone.

What is Reflux oesophagitis?

Reflux oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus) is found to be associated with 338 drugs and 570 conditions by eHealthMe. Check the latest studies of Reflux oesophagitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 22, 2026

58,374 people reported to have side effects when taking Methylprednisolone.
Among them, 21 people (0.04%) have Reflux oesophagitis.

Could Methylprednisolone cause Reflux oesophagitis?

Among these 21 people:

What is the gender of people who have Reflux oesophagitis when taking Methylprednisolone? *

female: 90.48 %
male: 9.52 %

What is the age of people who have Reflux oesophagitis when taking Methylprednisolone? *

What are other drugs people take besides Methylprednisolone? *

What are other side effects people have besides Reflux oesophagitis? *

Fever: 17 people, 80.95%
Infection: 17 people, 80.95%
Back Pain: 15 people, 71.43%
Dyspnea (difficult or laboured breathing): 15 people, 71.43%
Colitis (inflammation of colon): 14 people, 66.67%
Joint Pain: 14 people, 66.67%
Pain: 14 people, 66.67%
Fatigue (feeling of tiredness): 14 people, 66.67%
Diarrhea: 14 people, 66.67%
Abdominal Pain Upper: 14 people, 66.67%

What are the existing conditions these people have? *

Sleep Apnea Syndrome: 13 people, 61.90%
Bone Density Decreased: 12 people, 57.14%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 19.05%
Bone Loss: 1 person, 4.76%
Asthma: 1 person, 4.76%
Acute Myocardial Infarction (acute heart attack): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Methylprednisolone and have Reflux oesophagitis?

- Check whether Reflux oesophagitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methylprednisolone:

Methylprednisolone (59,645 reports)

Browse all side effects of Methylprednisolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Reflux oesophagitis:

Reflux oesophagitis (338 drugs)

Browse all the conditions that are associated with Reflux oesophagitis:

Reflux oesophagitis (570 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methylprednisolone (the active ingredients of Methylprednisolone) and Methylprednisolone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.